Daré Bioscience-Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates

Dare Bioscience, Inc. (DARE) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of$ 0.66. This compares to loss of $0.72 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 3.03%. A quarter ago, it was expected that this company would post a loss of$ 0.60 per share when it actually produced a loss of $0.55, delivering a surprise of 8.33%. Over the last four quarters, the company has su ...